BRIEF — Zealand Pharma, Generate Biomedicines Enter Collaboration, License Agreement

Oct 14 (Reuters) — Zealand Pharma A/S: Said On Tuesday Zealand Pharma And Generate Biomedicines Enter Collaboration And License Agreement To Develop Protein Therapeutics Engineered With Ai For Metabolic Diseases Zealand: Generate Will Receive Usd 30 Million Up-front, Up To Usd 35 Million In Early Preclinical Milestones, And A Total Of Nearly Usd 1.2 Billion In Milestones Source text:... Further company coverage: ZELA.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;)